Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Long-term effects of adolescent-onset and persistent use of cannabis.

Gonzalez R, Swanson JM.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):15970-1. doi: 10.1073/pnas.1214124109. No abstract available.

2.

Personality may explain the association between cannabis use and neuropsychological impairment.

Daly M.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E979. doi: 10.1073/pnas.1218571110. No abstract available.

3.

Persistent cannabis users show neuropsychological decline from childhood to midlife.

Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64. doi: 10.1073/pnas.1206820109.

4.

Reply to Rogeberg and Daly: No evidence that socioeconomic status or personality differences confound the association between cannabis use and IQ decline.

Moffitt TE, Meier MH, Caspi A, Poulton R.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E980-2. No abstract available.

5.

Marijuana and injury: is there a connection?

Brookoff D.

Ann Emerg Med. 1998 Sep;32(3 Pt 1):361-3. No abstract available.

PMID:
9737500
6.

The short-term consequences of early onset cannabis use.

Fergusson DM, Lynskey MT, Horwood LJ.

J Abnorm Child Psychol. 1996 Aug;24(4):499-512.

PMID:
8886945
7.

Adverse health effects of non-medical cannabis use.

Hall W, Degenhardt L.

Lancet. 2009 Oct 17;374(9698):1383-91. doi: 10.1016/S0140-6736(09)61037-0. Review.

PMID:
19837255
8.

Cannabis-related stroke: myth or reality?

Wolff V, Armspach JP, Lauer V, Rouyer O, Bataillard M, Marescaux C, Geny B.

Stroke. 2013 Feb;44(2):558-63. doi: 10.1161/STROKEAHA.112.671347. Review. No abstract available.

9.

Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Svrakic DM, Lustman PJ, Mallya A, Lynn TA, Finney R, Svrakic NM.

Mo Med. 2012 Mar-Apr;109(2):90-8. Review.

PMID:
22675784
10.

[Cannabis-induced cognitive and psychiatric disorders].

Dervaux A, Krebs MO, Laqueille X.

Bull Acad Natl Med. 2014 Mar;198(3):559-74; discussion 575-7. Review. French.

PMID:
26427297
11.

[Cannabis smoking and lung cancer].

Underner M, Urban T, Perriot J, de Chazeron I, Meurice JC.

Rev Mal Respir. 2014 Jun;31(6):488-98. doi: 10.1016/j.rmr.2013.12.002. Review. French.

PMID:
25012035
12.

Young brains on drugs.

DuPont RL, Lieberman JA.

Science. 2014 May 9;344(6184):557. doi: 10.1126/science.1254989. No abstract available.

13.

[Somatic consequences of cannabis use].

Cottencin O, Bence C, Rolland B, Karila L.

Rev Prat. 2013 Dec;63(10):1430-2. Review. French.

PMID:
24579346
14.

The cannabis experiment.

Cressey D.

Nature. 2015 Aug 20;524(7565):280-3. No abstract available. Erratum in: Nature. 2015 Sep 3;525(7567):17.

PMID:
26295084
15.

Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development.

Richardson GA, Day NL, Goldschmidt L.

Neurotoxicol Teratol. 1995 Jul-Aug;17(4):479-87.

PMID:
7565494
16.

A community survey of adverse effects of cannabis use.

Thomas H.

Drug Alcohol Depend. 1996 Nov;42(3):201-7.

PMID:
8912803
17.

Response to letter regarding article, “cannabis-related stroke: myth or reality?”.

Wolff V, Rouyer O, Gény B.

Stroke. 2013 May;44(5):e57. No abstract available.

18.

Letter by Parakh regarding article, "cannabis-related stroke: myth or reality?".

Parakh P.

Stroke. 2013 May;44(5):e56. doi: 10.1161/STROKEAHA.113.001092. No abstract available.

19.

Cannabis policy: time to move beyond the psychosis debate.

Werb D, Fischer B, Wood E.

Int J Drug Policy. 2010 Jul;21(4):261-4. doi: 10.1016/j.drugpo.2010.03.003. No abstract available.

PMID:
20381329
20.

The effect of marijuana use on the risk for schizophrenia.

Evins AE, Green AI, Kane JM, Murray RM.

J Clin Psychiatry. 2012 Nov;73(11):1463-8. doi: 10.4088/JCP.12012co1c. No abstract available.

Items per page

Supplemental Content

Support Center